Mirae Asset Global Investments’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.46K Sell
2,702
-372
-12% -$1.41K ﹤0.01% 1577
2026
Q1
$11.9K Buy
3,074
+210
+7% +$827 ﹤0.01% 1484
2025
Q4
$11.3K Buy
2,864
+720
+34% +$3.19K ﹤0.01% 1594
2025
Q3
$10K Buy
2,144
+6
+0.3% +$22 ﹤0.01% 1576
2025
Q2
$6.65K Buy
2,138
+310
+17% +$1K ﹤0.01% 1528
2025
Q1
$6.67K Buy
1,828
+8
+0.4% +$37 ﹤0.01% 1501
2024
Q4
$10.4K Sell
1,820
-152
-8% -$980 ﹤0.01% 1513
2024
Q3
$11.5K Buy
1,972
+348
+21% +$2.53K ﹤0.01% 1491
2024
Q2
$12.8K Buy
+1,624
New +$13.6K ﹤0.01% 1439
2024
Q1
Sell
-16,910
Closed -$143K 2659
2023
Q4
$143K Buy
16,910
+1,098
+7% +$7.96K ﹤0.01% 2399
2023
Q3
$123K Hold
15,812
﹤0.01% 2422
2023
Q2
$181K Buy
+15,812
New +$164K ﹤0.01% 2377
2021
Q4
Sell
-170,075
Closed -$447K 1770
2021
Q3
$447K Buy
170,075
+31,994
+23% +$104K ﹤0.01% 1517
2021
Q2
$571K Buy
+138,081
New +$626K ﹤0.01% 1417
2021
Q1
Sell
-29,987
Closed -$215K 1627
2020
Q4
$215K Buy
29,987
+7,852
+35% +$75.5K ﹤0.01% 1501
2020
Q3
$236K Buy
22,135
+7,017
+46% +$82.4K ﹤0.01% 1392
2020
Q2
$191K Buy
+15,118
New +$176K ﹤0.01% 1403

Other funds holding VYGR

Mirae Asset Global Investments's VYGR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Voyager Therapeutics (VYGR) stake by 12% in Q2 2026, selling an estimated $1.41K and leaving 2,702 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Mirae Asset Global Investments first reported a position in VYGR in Q2 2020 and has held it in 17 quarters since. The position peaked at $571K in Q2 2021. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Mirae Asset Global Investments held 2,702 shares of Voyager Therapeutics worth $9.46K as of Q2 2026.
  • Mirae Asset Global Investments sold 372 Voyager Therapeutics shares in Q2 2026, an estimated $1.41K.
  • Voyager Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1577 holding.
  • Mirae Asset Global Investments first reported a position in Voyager Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Voyager Therapeutics position peaked at $571K in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.